AstraZeneca announced the opening of its newest global strategic research and development (R&D) centre, in Kendall Square, Cambridge, Massachusetts. The new state-of-the-art facility builds on the Company’s existing presence in Cambridge and Boston and places its scientists at the heart of one of the world’s most innovative life sciences ecosystems.
Pascal Soriot, Chief Executive Officer, AstraZeneca, said: “Kendall Square is a leading innovation ecosystem, and it is one of the key locations where AstraZeneca will discover the next generation of scientific breakthroughs. Our new R&D centre not only reflects AstraZeneca’s long-term commitment to Massachusetts but also our belief in delivering US-led innovation to patients around the world.”
he opening of these laboratories marks a significant milestone in AstraZeneca’s more than 75-year history in Massachusetts. As part of its broader US investment of $50 billion, AstraZeneca is investing more than $1 billion in Massachusetts, which will directly expand its workforce in the state by over 50 per cent in the coming years and contribute billions in additional economic value and jobs across the Commonwealth.
Maura Healey, Governor of Massachusetts, said: “Massachusetts leads the world in life sciences because we bring together the best talent, institutions and ideas to solve hard problems and improve people’s lives. AstraZeneca’s more than $1 billion investment is a major vote of confidence in Massachusetts and the extraordinary talent we have here. We’re excited to see the future of medicine take shape in Kendall Square, and we’re grateful to AstraZeneca for continuing to grow its presence in our state. Massachusetts is a global leader in life sciences, and we’re going to keep competing for the investments, jobs and breakthroughs that will define the next generation of medicine.”
The opening of these laboratories marks a significant milestone in AstraZeneca’s more than 75-year history in Massachusetts. As part of its broader US investment of $50 billion, AstraZeneca is investing more than $1 billion in Massachusetts, which will directly expand its workforce in the state by over 50 per cent in the coming years and contribute billions in additional economic value and jobs across the Commonwealth